Form 4 for CRL Charles River Laboratories
Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001127602-24-021581 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-05 | 2024-08-01 | CRL | FOSTER JAMES C | COB, Pres, CEO, Dir | S - Sale | $250.00 | -25.0K | 188.3K | -12% | -$6.25M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 25,000 | $250.00 | 188,251 | D | — | — | (F1) This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 26, 2024. |